Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
16 drugs in development
By Therapeutic Area
top 6
R&D Momentum
90/100
Pipeline Velocity
66/100
Trial Completion Rate
77/100
Pipeline Concentration
12/100
Pipeline Freshness
76/100
Strategic Signals
Activity
Last 14 days
Collaborative Specialty Care for Gulf War Illness
The EMBER Trial for Weight Management Engagement
A Novel Peer-Delivered Recovery-Focused Suicide Prevention Intervention for Veterans With Serious Mental Illness
Stimulating the Vagus Nerve to Improve Gait in Veterans With Parkinson's Disease
CSP #2018 - Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)
Public Messaging to Increase Treatment Seeking Among Veterans at Risk for Suicide During Transition From Military Service
A New Intervention to Improve Function in Veterans With Anxiety and Depression
Effects of Neuromodulation and Cognitive Training for Suicide in Veterans (ENACTS)
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)